Ali Behbahani Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is a 10% Owner in Marker Therapeutics, Inc. ($MRKR) and a Director in NEVRO CORP ($NVRO) and a Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and a 10% Owner in Regulus Therapeutics Inc. ($RGLS) and a 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a 10% Owner in Metacrine, Inc. ($MTCR) and a Director in CRISPR Therapeutics AG ($CRSP) and a Director in Black Diamond Therapeutics, Inc. ($BDTX) and a Director in Oyster Point Pharma, Inc. ($OYST) and a 10% Owner in Akouos, Inc. ($AKUS) and a 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and a Director in Nkarta, Inc. ($NKTX).

Address: 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM 21093 MD

Companies in which Ali Behbahani is an Insider

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 19,500,000 shares
Current Value: $88,335,000
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Akouos, Inc.

Trading Symbol: AKUS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 513,758 shares
Latest Transaction: Jul 01 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 547 shares
Latest Transaction: Mar 22 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 256 shares
Current Value: $4,032
Latest Transaction: Aug 14 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOCEA BIOSCIENCES, INC.

Trading Symbol: GNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 10,376,936 shares
Current Value: $46,799,981
Latest Transaction: Jul 28 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Marker Therapeutics, Inc.

Trading Symbol: MRKR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 10,714,285 shares
Current Value: $47,678,568
Latest Transaction: Mar 18 2021
$MRKR Market Capitalization: $36.11M
$MRKR Previous Close: $4.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Metacrine, Inc.

Trading Symbol: MTCR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 1,958,333 shares
Latest Transaction: Sep 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Mirum Pharmaceuticals, Inc.

Trading Symbol: MIRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 3,736,243 shares
Latest Transaction: Jul 24 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEVRO CORP

Trading Symbol: NVRO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Ali Behbahani: Director
Holdings: 5,390 shares
Current Value: $503,049
Latest Transaction: May 23 2018
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Nkarta, Inc.

Trading Symbol: NKTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: Director
Holdings: 0 shares
Latest Transaction: Jul 13 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Oyster Point Pharma, Inc.

Trading Symbol: OYST
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 6,600 shares
Latest Transaction: Jun 10 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Regulus Therapeutics Inc.

Trading Symbol: RGLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 6,451,056 shares
Current Value: $9,031,478
Latest Transaction: Dec 07 2020
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Trevi Therapeutics, Inc.

Trading Symbol: TRVI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 5,938,562 shares
Latest Transaction: Apr 13 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Ali Behbahani

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 22 2021	BDTX	Black Diamond Ther ...	Behbahani Ali	Director	Grant	A	24.01	547	13,133	547	0 to 547
Mar 18 2021	MRKR	Marker Therapeutic ...	Behbahani Ali	10% Owner	Buy	P	1.75	5,714,285	9,999,999	10,714,285	5 M to 10.7 M (+114.29 %)
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.00	258,707	0	258,707
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Option Exercise	P	0.75	5,239,254	3,910,579	5,239,254
Dec 07 2020	RGLS	Regulus Therapeuti ...	Behbahani Ali	10% Owner	Buy	P	0.62	4,398,602	2,735,930	6,451,056	2.1 M to 6.5 M (+214.31 %)
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	332,964	0	0
Sep 22 2020	MTCR	Metacrine, Inc.	Behbahani Ali	10% Owner	Option Exercise	C	0.00	1,958,333	0	0

View all Ali Behbahani insider transactions.